BRCA2 and sarcoma: Four genes (BRCA2, CDK12, MLL2, and VHL) were differentially mutated (p-value < 0.05) between renal cell carcinoma patients and sarcoma patients; however, these differences were not significant when correcting for multiple comparisons (FDR q-values >0.5).